Clinical Trials

Glioblastoma, Neoplasms

NCT04755023 2026-05-07

TEMOBIC

Phase 2 Completed

53 enrolled

Astrocytoma, Oligodendroglioma

NCT04728633 2026-05-06

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

DermatologicLymphoidOther hematologic neoplasm

28 enrolled

Dermatologic

Uveal Melanoma

NCT00641381 2026-05-04

Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Phase 1 Completed

25 enrolled

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04222062 2026-04-28

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

100 enrolled

Brain Neoplasms

NCT05521984 2026-04-02

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Phase 1 Recruiting

20 enrolled

Other solid neoplasm

Pediatric Brain Tumor

NCT06692452 2026-04-01

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

Phase 2 Withdrawn

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Peripheral, Enteropathy-Associated T-Cell Lymphoma

NCT06687772 2026-03-31

CNS-PHLAT

36 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT06915246 2026-03-27

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

49 enrolled

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

53 enrolled

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

NCT01511562 2026-01-30

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

113 enrolled 14 charts

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT04150042 2026-01-29

SHARON

Phase 1 Recruiting

24 enrolled

BreastGastrointestinal

Breast Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

NCT02896582 2026-01-14

LyMa101

Phase 2 Completed

86 enrolled

Lymphoma, Mantle-Cell

NCT04871607 2025-12-04

Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

33 enrolled

Phase 1 Active not recruiting

Hodgkin Disease

NCT01840566 2025-12-03

High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma

17 enrolled

Lymphoma, Non-Hodgkin, Recurrence

NCT06626516 2025-11-28

Tebentafusp-tebn With LDT in Metastatic UM

Phase 1/2 Recruiting

109 enrolled

Dermatologic

Uveal Melanoma, Melanoma

NCT02570542 2025-11-26

Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

59 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT05052957 2025-11-21

hSTAR GBM

16 enrolled

Glioblastoma

NCT03125642 2025-11-04

Auto Stem Cell Transplant for Lymphoma Patients